Page 3 of 12 – SEC Filing CUSIP No. 737010108 13G Page 3 of 12 Pages
1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Deerfield Management Company, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) o (b) ý 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 3,089,785 (2) 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,089,785 (2) 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,089,785 (2) 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* o 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.48% 12. TYPE OF REPORTING PERSON* PN
(2) Comprised of shares of common stock held by Deerfield Partners, L.P., Deerfield International Master Fund, L.P. and Deerfield Special Situations Fund, L.P., of which Deerfield Management Company, L.P. is the investment advisor. Follow Portola Pharmaceuticals Inc (NASDAQ:PTLA)
Follow Portola Pharmaceuticals Inc (NASDAQ:PTLA)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. | 737010108 | 13G | Page 3 of 12 Pages |
| 1. | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Deerfield Management Company, L.P. | ||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* | (a) o (b) ý | |
| 3. | SEC USE ONLY | ||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 | |
| 6. | SHARED VOTING POWER 3,089,785 (2) | ||
| 7. | SOLE DISPOSITIVE POWER 0 | ||
| 8. | SHARED DISPOSITIVE POWER 3,089,785 (2) | ||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,089,785 (2) | ||
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* | o | |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.48% | ||
| 12. | TYPE OF REPORTING PERSON* PN | ||
(2) Comprised of shares of common stock held by Deerfield Partners, L.P., Deerfield International Master Fund, L.P. and Deerfield Special Situations Fund, L.P., of which Deerfield Management Company, L.P. is the investment advisor.
Follow Portola Pharmaceuticals Inc (NASDAQ:PTLA)
Follow Portola Pharmaceuticals Inc (NASDAQ:PTLA)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
